Venbio Select Advisor Llc - Net Worth and Insider Trading
Venbio Select Advisor Llc Net Worth
The estimated net worth of Venbio Select Advisor Llc is at least $163 Million dollars as of 2023-09-26. Venbio Select Advisor Llc is the 10% Owner of Mirati Therapeutics Inc and owns about 3,800,000 shares of Mirati Therapeutics Inc (MRTX) stock worth over $154 Million. Venbio Select Advisor Llc is also the of Immunomedics Inc and owns about 100,000 shares of Immunomedics Inc (IMMU) stock worth over $9 Million. Details can be seen in Venbio Select Advisor Llc's Latest Holdings Summary section.
Transaction Summary of Venbio Select Advisor Llc
Venbio Select Advisor Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Venbio Select Advisor Llc owns 4 companies in total, including CymaBay Therapeutics Inc (CBAY) , Immunomedics Inc (IMMU) , and Mirati Therapeutics Inc (MRTX) among others .
Click here to see the complete history of Venbio Select Advisor Llc’s form 4 insider trades.
Insider Ownership Summary of Venbio Select Advisor Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2020-08-03 | 10 percent owner |
| IMMU | Immunomedics Inc | 2020-06-18 | director & 10 percent owner & other: See Remarks |
| MRTX | Mirati Therapeutics Inc | 2017-09-15 | 10 percent owner |
| AADI | Aadi Bioscience Inc | 2021-08-26 | director & other: See Remarks |
Venbio Select Advisor Llc Latest Holdings Summary
Venbio Select Advisor Llc currently owns a total of 2 stocks. Among these stocks, Venbio Select Advisor Llc owns 3,800,000 shares of Mirati Therapeutics Inc (MRTX) as of July 23, 2019, with a value of $154 Million and a weighting of 94.62%. Venbio Select Advisor Llc also owns 100,000 shares of Immunomedics Inc (IMMU) as of May 1, 2020, with a value of $9 Million and a weighting of 5.38%.
Latest Holdings of Venbio Select Advisor Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2019-07-23 | 3,800,000 | 40.65 | 154,470,000 |
| IMMU | Immunomedics Inc | 2020-05-01 | 100,000 | 87.86 | 8,786,000 |
Holding Weightings of Venbio Select Advisor Llc
Venbio Select Advisor Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Venbio Select Advisor Llc has made a total of 3 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 62,500 shares on July 23, 2019, which brought Venbio Select Advisor Llc around $6 Million.
According to the SEC Form 4 filings, Venbio Select Advisor Llc has made a total of 6 transactions in Immunomedics Inc (IMMU) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Immunomedics Inc is the acquisition of 1,750,000 shares on May 1, 2020, which cost Venbio Select Advisor Llc around $50 Million.
Insider Trading History of Venbio Select Advisor Llc
- 1
Venbio Select Advisor Llc Trading Performance
GuruFocus tracks the stock performance after each of Venbio Select Advisor Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Venbio Select Advisor Llc is 17.22%. GuruFocus also compares Venbio Select Advisor Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Venbio Select Advisor Llc within 3 months outperforms 7 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Venbio Select Advisor Llc's insider trading performs compared to the benchmark.
Performance of Venbio Select Advisor Llc
Average Relative Return
125.04%
Outperforming Transactions
78%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 6.57 | 17.22 | 40.48 | 125.04 | 45.99 | 92.29 |
| Relative Return to S&P 500(%) | 3.29 | 12.26 | 38.09 | 118.98 | 39.16 | 78.76 |
Venbio Select Advisor Llc Ownership Network
Ownership Network List of Venbio Select Advisor Llc
Ownership Network Relation of Venbio Select Advisor Llc
Venbio Select Advisor Llc Owned Company Details
What does CymaBay Therapeutics Inc do?
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and MBX-2982 (a GPR119 agonist).
Who are the key executives at CymaBay Therapeutics Inc?
Venbio Select Advisor Llc is the 10 percent owner of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Financial Officer Harish Shantharam , Vice President & Finance Daniel Menold , and Chief Scientific Officer Charles Mcwherter .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Venbio Select Advisor Llc made no insider transaction in CymaBay Therapeutics Inc (CBAY). Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 108,739 shares made by Charles Mcwherter , a net sale of 73,000 shares made by Paul T Quinlan , and a net sale of 120,100 shares made by Dennis D Kim .
In summary, during the past 3 months, insiders sold 154,186 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 154,186 shares. During the past 18 months, 322,784 shares of CymaBay Therapeutics Inc (CBAY) were sold and 51,301 shares were bought by its insiders, resulting in a net sale of 271,483 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Venbio Select Advisor Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Venbio Select Advisor Llc. You might contact Venbio Select Advisor Llc via mailing address: 110 Greene Street, Suite 800, New York Ny 10012.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
